Answers are grounded in this paper and cite their sources.
This case report presents the response to experimental drug gilteritinib hemifumarate in a patient with ophthalmological complications of relapsed acute myeloid leukemia with FMS-like tyrosine kinase 3 (FLT3) gene mutation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: